Seiji Mori

1.3k total citations
45 papers, 1000 citations indexed

About

Seiji Mori is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, Seiji Mori has authored 45 papers receiving a total of 1000 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 18 papers in Molecular Biology and 15 papers in Oncology. Recurrent topics in Seiji Mori's work include Cell Adhesion Molecules Research (11 papers), Bone and Dental Protein Studies (9 papers) and Fibroblast Growth Factor Research (7 papers). Seiji Mori is often cited by papers focused on Cell Adhesion Molecules Research (11 papers), Bone and Dental Protein Studies (9 papers) and Fibroblast Growth Factor Research (7 papers). Seiji Mori collaborates with scholars based in Japan, United States and Taiwan. Seiji Mori's co-authors include Nariaki Matsuura∥, Naomasa Kawaguchi, Yoshinosuke Hamada, Yoshikazu Takada, Yoko K. Takada, Hirofumi Yamamoto, Ayako Uchinaka, Motonari Tanaka, Hiroshi Ishiguro and Yoshiki Sawa and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Seiji Mori

42 papers receiving 989 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Seiji Mori Japan 20 490 289 192 179 168 45 1000
Minlong Shi China 7 549 1.1× 200 0.7× 213 1.1× 95 0.5× 104 0.6× 7 1.1k
Suzanne Spong United States 11 729 1.5× 307 1.1× 194 1.0× 108 0.6× 204 1.2× 12 1.4k
Ulla Impola Finland 20 585 1.2× 292 1.0× 239 1.2× 221 1.2× 455 2.7× 29 1.4k
Catherine Maillard Belgium 20 444 0.9× 329 1.1× 143 0.7× 147 0.8× 504 3.0× 28 1.4k
Yoshiya Shimao Japan 15 508 1.0× 350 1.2× 166 0.9× 96 0.5× 246 1.5× 43 1.2k
Ken‐ichi Iyama Japan 19 363 0.7× 278 1.0× 95 0.5× 247 1.4× 190 1.1× 58 1.2k
Mumtaz V. Rojiani United States 14 537 1.1× 169 0.6× 182 0.9× 52 0.3× 281 1.7× 29 931
Henrik J. Jürgensen Denmark 18 322 0.7× 290 1.0× 211 1.1× 107 0.6× 282 1.7× 25 1.1k
Shinji Iizuka Japan 15 444 0.9× 247 0.9× 100 0.5× 85 0.5× 260 1.5× 22 909
Lior Zilberberg United States 20 824 1.7× 198 0.7× 223 1.2× 162 0.9× 275 1.6× 24 1.7k

Countries citing papers authored by Seiji Mori

Since Specialization
Citations

This map shows the geographic impact of Seiji Mori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seiji Mori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seiji Mori more than expected).

Fields of papers citing papers by Seiji Mori

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seiji Mori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seiji Mori. The network helps show where Seiji Mori may publish in the future.

Co-authorship network of co-authors of Seiji Mori

This figure shows the co-authorship network connecting the top 25 collaborators of Seiji Mori. A scholar is included among the top collaborators of Seiji Mori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seiji Mori. Seiji Mori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chang, Chih-Chieh, Yoko K. Takada, Yoko K. Takada, et al.. (2024). FGF9, a Potent Mitogen, Is a New Ligand for Integrin αvβ3, and the FGF9 Mutant Defective in Integrin Binding Acts as an Antagonist. Cells. 13(4). 307–307. 2 indexed citations
2.
Uchinaka, Ayako, Yoshinosuke Hamada, Seiji Mori, et al.. (2018). Overexpression of collagen type III in injured myocardium prevents cardiac systolic dysfunction by changing the balance of collagen distribution. Journal of Thoracic and Cardiovascular Surgery. 156(1). 217–226.e3. 26 indexed citations
3.
Mori, Seiji, Naomasa Kawaguchi, Yoshinosuke Hamada, et al.. (2017). The integrin-binding defective FGF2 mutants potently suppress FGF2 signalling and angiogenesis. Bioscience Reports. 37(2). 41 indexed citations
4.
Uchinaka, Ayako, Naomasa Kawaguchi, Yoshinosuke Hamada, et al.. (2017). Evaluation of dermal wound healing activity of synthetic peptide SVVYGLR. Biochemical and Biophysical Research Communications. 491(3). 714–720. 12 indexed citations
6.
Uchinaka, Ayako, Yoshinosuke Hamada, Seiji Mori, et al.. (2015). SVVYGLR motif of the thrombin-cleaved N-terminal osteopontin fragment enhances the synthesis of collagen type III in myocardial fibrosis. Molecular and Cellular Biochemistry. 408(1-2). 191–203. 30 indexed citations
7.
Uchinaka, Ayako, Naomasa Kawaguchi, Seiji Mori, et al.. (2014). Tissue Inhibitor of Metalloproteinase-1 and -3 Improves Cardiac Function in an Ischemic Cardiomyopathy Model Rat. Tissue Engineering Part A. 20(21-22). 3073–3084. 27 indexed citations
8.
Mori, Seiji, Yoshinosuke Hamada, Naomasa Kawaguchi, et al.. (2013). A Dominant-Negative FGF1 Mutant (the R50E Mutant) Suppresses Tumorigenesis and Angiogenesis. PLoS ONE. 8(2). e57927–e57927. 52 indexed citations
9.
Uchinaka, Ayako, Naomasa Kawaguchi, Yoshinosuke Hamada, et al.. (2012). Transplantation of elastin-secreting myoblast sheets improves cardiac function in infarcted rat heart. Molecular and Cellular Biochemistry. 368(1-2). 203–214. 11 indexed citations
10.
Yamaji, Satoshi, Jun Saegusa, Katsuaki Ieguchi, et al.. (2010). A Novel Fibroblast Growth Factor-1 (FGF1) Mutant that Acts as an FGF Antagonist. PLoS ONE. 5(4). e10273–e10273. 21 indexed citations
11.
Fujitani, Wataru, Yoshinosuke Hamada, Naomasa Kawaguchi, et al.. (2010). Synthesis of Hydroxyapatite Contining Manganese and Its Evaluation of Biocompatibility. 2(1). 37–46. 19 indexed citations
12.
Ito, Emiko, Ikuo Yana, Maki Takeda, et al.. (2010). The role of MT2-MMP in cancer progression. Biochemical and Biophysical Research Communications. 393(2). 222–227. 26 indexed citations
13.
Chuang, Chia-Chen, et al.. (2006). Non-cytotoxic Cobra Cardiotoxin A5 Binds to αvβ3 Integrin and Inhibits Bone Resorption. Journal of Biological Chemistry. 281(12). 7937–7945. 45 indexed citations
14.
Yamamoto, Yasuko, Eiichiro Hirakawa, Seiji Mori, et al.. (2005). Cleavage of carcinoembryonic antigen induces metastatic potential in colorectal carcinoma. Biochemical and Biophysical Research Communications. 333(1). 223–229. 32 indexed citations
15.
Fu, Yao, Yoshio Kushida, Kousuke Saoo, et al.. (2000). Sarcomatoid hepatocellular carcinoma with chondroid variant: Case report with immunohistochemical findings. Pathology International. 50(11). 919–922. 13 indexed citations
16.
Karasawa, Yukihiko, et al.. (1997). A CASE OF LEIOMYOSARCOMA OF THE ASCENDING COLON ASSOCIATED WITH INTUSSUSCEPTION. The journal of the Japanese Practical Surgeon Society. 58(3). 639–642.
17.
Hamamoto, Isao, et al.. (1996). Impact of adhesion molecules of the selectin family on liver microcirculation at reperfusion following cold ischemia. Transplant International. 9(5). 454–460. 13 indexed citations
18.
Yamamoto, Shinya, et al.. (1994). Two Cases of Resected Small Intestinal Metastases from Primary Carcinoma of the Lung.. The Japanese Journal of Gastroenterological Surgery. 27(7). 1853–1857. 1 indexed citations
19.
Hirakawa, Eiichiro, Reiji Haba, Hiroshi Miki, et al.. (1994). Giant symptomatic myelolipoma of the adrenal gland. Pathology International. 44(10-11). 800–802. 1 indexed citations
20.
Haba, Reiji, Shōji Kobayashi, Hiroshi Miki, et al.. (1993). Mixed mesodermal tumor of the ovary: Immunohistochemical study with histogenetic consideration. Acta Pathologica Japonica. 43(11). 696–701. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026